Selected Publications (click for a complete list through PubMed)

Sood, AK, Saxena, R, Groth, J, Desouki, MM, Cheewakriangkrai, C, Rodabaugh, KJ, Kasyapa, CS and Geradts, J. Expression characteristics of PDEF support a role in breast and prostate cancer progression. Hum. Immunol. In Press, 2007.

Rodabaugh, K., Mhavech-Fauceglia, P, Lele, S and Sood, A.K. Prostate Derived Ets Factor (PDEF) is over expressed in Serous Epithelial Ovarian Tumors. Internation. J. of Gynecol Path. 26;1:10-15, 2007.

Ghadersohi, A., Odunsi, K., Lele, S., Collins, Y., Greco, WR, Winston, J, Liang, P and Sood, A.K. Prostate- derived Ets factor shows better tumor-association than other cancer-associated molecules. Oncol. Rep. 11: 453-458, 2004.

Qian F, Gnjatic S, Jager E, Santiago D, Jungbluth A, Grande C, Schneider S, Keitz B, Driscoll D, Ritter G, Lele S, Sood A, Old LJ, Odunsi K Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer. Cancer Immun. 4:12, 2004.

Ghadersohi, A., Chitta, K., Greco W.R., Harvey, S., Winston, J., Slocum, H., Odunsi, K. and Sood, A.K. Tumor antigens and markers for breast and ovarian cancers. Frontiers in Bioscience 7:e48-57, 2002.

Ghadersohi, A. and Sood, A.K. Prostate epithelium-derived Ets transcription factor mRNA is over expressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin. Cancer Res. 7:2731-2738, 2001.

Sood, A.K., Hsu, S-C., Chakravarty, P.K., Nadadur, S.S. and Abu-hadid, M.M. Cancer vaccines: Problems and promises. Recent Res. Devel. Immunol. 2:89-116, 2000.

Santra, S., Sood, A.K. and Ghosh, S.K. Vaccination-induced CD8+ cytotoxic T cells are distinctly different from those generated during active growth of a murine B-cell lymphoma. Cancer Immunol. Immunother. 48:421-429, 1999.

Hsu, S-C., Glaves-Rapp, D. and Sood, A.K. IL-2 secretion by KHT sarcoma cells leads to loss of their vaccine potential. Cancer Immunol. Immunother. 44: 117-124, 1997.

Abu-hadid, M.M., Fuji, H., Hsu, S-C. and Sood, A.K. A one step PCR procedure for analysis of tumor specific T lymphocyte responses. J. Immunol. Methods 190: 91-105, 1996.